Fisher & Paykel Healthcare Co. Limited (OTCMKTS:FSPKF) Stock Short Interest Report for October

Fisher & Paykel Healthcare Co. Limited (OTCMKTS:FSPKF) was the recipient of a large growth in short interest during the month of October. As of October 30th, there was short interest totaling 192,457 shares, a growth of 1,629.0% from the October 15th total of 11,131 shares. Based on an average trading volume of 648 shares, the days-to-cover ratio is presently 297.0 days.

Fisher & Paykel Healthcare Price Performance

Shares of FSPKF stock remained flat at $26.99 during mid-day trading on Thursday. Fisher & Paykel Healthcare has a 52-week low of $19.01 and a 52-week high of $28.09. The company has a fifty day moving average price of $26.40 and a 200-day moving average price of $23.81.

Analysts Set New Price Targets

FSPKF has been the topic of a number of research reports. Royal Bank Of Canada upgraded shares of Fisher & Paykel Healthcare from a “sector perform” rating to an “outperform” rating in a report on Tuesday, September 15th. Citigroup raised shares of Fisher & Paykel Healthcare to a “buy” rating in a research note on Thursday, September 10th. Two research analysts have rated the stock with a Buy rating. According to data from MarketBeat.com, the company currently has a consensus rating of “Buy”.

Fisher & Paykel Healthcare Company Profile

Fisher & Paykel Healthcare Corporation Limited is a New Zealand-based medical device company that develops, manufactures and markets products for respiratory care, acute care and home healthcare. Its technologies are designed to help patients breathe more comfortably and effectively across hospital and home settings. The company’s product portfolio includes respiratory humidification systems, nasal high-flow therapy products, continuous positive airway pressure (CPAP) and noninvasive ventilation masks, as well as related circuits, interfaces and consumables.